Industry News

Screening available for HCV Q80K polymorphism

December 6, 2013
An enhanced version of Laboratory Corp. of America’s HCV GenoSure NS3/4 test capable of determining whether patients have the hepatitis C virus…
Regulatory News

HCV treatment given orphan drug status

December 5, 2013
The FDA granted orphan drug status to MassBiologics for MBL-HCV1, a monoclonal antibody designed to prevent recurrence of hepatitis C in patients…
In the Journals

HCV can remain infective for weeks on inanimate surfaces

December 4, 2013
A Yale research team determined that hepatitis C virus can maintain its infectivity for up to 6 weeks on various surfaces, suggesting a potential…
Meeting News Coverage

Low SVR rates observed in HCV/HIV patients assigned peginterferon/ribavirin in clinical practice

November 26, 2013
WASHINGTON — With liver disease now the leading cause of death among patients coinfected with HIV and hepatitis C, treatment of the HCV…
FDA approvals

Simeprevir combination therapy approved as hepatitis C treatment

November 25, 2013
The FDA has approved simeprevir as part of an antiviral treatment regimen with pegylated interferon and ribavirin for the treatment of patients with…
Industry News

SVR12 demonstrated in 96% of treatment-naive HCV patients in early phase 3 trial results

November 25, 2013
An all-oral, interferon-free, 12-week therapy achieved sustained virologic response in 96% of patients with chronic hepatitis C genotype 1, according…
In the Journals

Antidepressant prophylaxis failed to improve HCV treatment completion

November 22, 2013
Prophylactic antidepressant use did not boost interferon-based treatment completion in patients with hepatitis C infection, according to the results…
In the Journals

HCV reinfection, spontaneous clearance high among injection drug users

November 21, 2013
Researchers from Australia reported a high rate of hepatitis C virus reinfection and spontaneous clearance of reinfection among injection drug users…
Meeting News Coverage

HCC-based transplants straining donor pool, speaker says

November 20, 2013
WASHINGTON — The increase in the number of hepatocellular carcinoma patients in the United States being wait-listed for transplant is leading…
FDA News

OxyElite Pro products recalled after being linked to liver failure, hepatitis, death

November 19, 2013
USPLabs of Dallas is recalling specific OxyElite Pro dietary supplements in response to a letter from the FDA stating the products were linked to…